Oral Contraceptive Pills Market by Type (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Category, Distribution - Global Forecast 2024-2030

Oral Contraceptive Pills Market by Type (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Category, Distribution - Global Forecast 2024-2030


The Oral Contraceptive Pills Market size was estimated at USD 17.33 billion in 2023 and expected to reach USD 18.36 billion in 2024, at a CAGR 6.76% to reach USD 27.41 billion by 2030.

Global Oral Contraceptive Pills Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Oral Contraceptive Pills Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oral Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Oral Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Azesto Impex Private Limited, Bayer AG, HLL Lifecare Limited, Insud Pharma, Johnson & Johnson Services, Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co. Inc., Mithra Pharmaceuticals, SA, Mylan N.V., Perrigo Company PLC, Pfizer Inc., Piramal Pharma Solutions, Sanofi SA, Syzygy Healthcare Solutions LLC, Teva Pharmaceuticals Industries Ltd., TherapeuticsMD, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Oral Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Combination Pill
Continuous/Extended Pill
Progesterone Pill
Age Group
15-24
25-34
35-44
45 and Above
Category
Branded
Generic
Distribution
Offline
Online
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Oral Contraceptive Pills Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oral Contraceptive Pills Market?
3. What are the technology trends and regulatory frameworks in the Oral Contraceptive Pills Market?
4. What is the market share of the leading vendors in the Oral Contraceptive Pills Market?
5. Which modes and strategic moves are suitable for entering the Oral Contraceptive Pills Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Oral Contraceptive Pills Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption owing to unintended pregnancies
5.1.1.2. Government and NGO initiatives to promote contraceptive pills
5.1.1.3. Increasing prevalence of sexually transmitted diseases (STDs)
5.1.2. Restraints
5.1.2.1. Adverse health impacts of contraceptive pills
5.1.3. Opportunities
5.1.3.1. Advancements in the formulations of oral contraceptive pills
5.1.3.2. Improving access to birth control with telehealth services and favourable government approvals
5.1.4. Challenges
5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Oral Contraceptive Pills Market, by Type
6.1. Introduction
6.2. Combination Pill
6.3. Continuous/Extended Pill
6.4. Progesterone Pill
7. Oral Contraceptive Pills Market, by Age Group
7.1. Introduction
7.2. 15-24
7.3. 25-34
7.4. 35-44
7.5. 45 and Above
8. Oral Contraceptive Pills Market, by Category
8.1. Introduction
8.2. Branded
8.3. Generic
9. Oral Contraceptive Pills Market, by Distribution
9.1. Introduction
9.2. Offline
9.3. Online
10. Americas Oral Contraceptive Pills Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Oral Contraceptive Pills Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Oral Contraceptive Pills Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbvie Inc.
14.1.2. Acme Generics Pvt. Ltd.
14.1.3. Afaxys, Inc.
14.1.4. Agile Therapeutics, Inc.
14.1.5. Amneal Pharmaceuticals LLC
14.1.6. Aurobindo Pharma Limited
14.1.7. Azesto Impex Private Limited
14.1.8. Bayer AG
14.1.9. HLL Lifecare Limited
14.1.10. Insud Pharma
14.1.11. Johnson & Johnson Services, Inc.
14.1.12. Lupin Limited
14.1.13. Mankind Pharma Ltd.
14.1.14. Mayne Pharma Group Limited
14.1.15. Merck & Co. Inc.
14.1.16. Mithra Pharmaceuticals, SA
14.1.17. Mylan N.V.
14.1.18. Perrigo Company PLC
14.1.19. Pfizer Inc.
14.1.20. Piramal Pharma Solutions
14.1.21. Sanofi SA
14.1.22. Syzygy Healthcare Solutions LLC
14.1.23. Teva Pharmaceuticals Industries Ltd.
14.1.24. TherapeuticsMD, Inc.
14.1.25. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. ORAL CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
FIGURE 2. ORAL CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
FIGURE 3. ORAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ORAL CONTRACEPTIVE PILLS MARKET DYNAMICS
FIGURE 7. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 10. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
FIGURE 12. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 14. ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ORAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ORAL CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. ORAL CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings